Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|March 11, 2014
Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancerRobert J Myerson, Benjamin Tan, Steven Hunt, et al.
Cancer Chemotherapy and Pharmacology|June 12, 2014
A phase I study of pegylated liposomal doxorubicin and temsirolimus in patients with refractory solid malignanciesAndrea Wang-Gillam, Nilay Thakkar, A Craig Lockhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancerSteven J Cohen, Cornelis J A Punt, Nicholas Iannotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell CarcinomaSumanta K Pal, Alice Bernard-Tessier, Peter Grell, et al.
JCO Precision Oncology|September 9, 2020
Cell-free DNA alterations in the AR enhancer and locus predict resistance to AR-directed therapy in patients with metastatic prostate cancerHa X Dang, Pradeep S Chauhan, Haley Ellis, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2008
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignanciesPaula M Fracasso, Joel Picus, Jonathan D Wildi, et al.
The Prostate|May 10, 2022
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805Alicia K Morgans, Yu-Hui Chen, David F Jarrard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2017
Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without DocetaxelLauren C Harshman, Yu-Hui Chen, Glenn Liu, et al.
The New England Journal of Medicine|August 6, 2015
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerChristopher J Sweeney, Yu-Hui Chen, Michael Carducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2023
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial CarcinomaDaniel P Petrylak, Bernhard J Eigl, Saby George, et al.
Pageof 10